Cingulate Inc.
CING- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001862150
No open-market purchases or sales by Cingulate Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $9.88M in total; no superinvestor holds it.
Other share classesCINGW
Q2 2025 vs. Q1 2025
How the institutions holding Cingulate Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 9 | 15 | +6 |
| Shares | 131.6K | 290.2K | +158.6K (+120.5%) |
| Value | $566.1K | $1.18M | +$615.2K (+108.7%) |
New holders (6)
Institutions that held Cingulate Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 33,201 | $135.1K | 0.00% |
| Virtu Financial LLC | 13,351 | $54.0K | 0.00% |
| LPL Financial LLC | 12,175 | $49.6K | 0.00% |
| XTX Topco Ltd | 10,943 | $44.5K | 0.00% |
| Citigroup Inc | 311 | $1.27K | 0.00% |
| Raymond James Financial Inc | 39 | $159 | 0.00% |
Sold out (0)
Institutions that held Cingulate Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
None.